Keystone Financial Planning’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $933K | Sell |
21,872
-144
| -0.7% | -$6.43K | 0.24% | 29 |
|
|
2026
Q1 | $1.06M | Hold |
22,016
| – | – | 0.28% | 30 |
|
|
2025
Q4 | $1.07M | Buy |
22,016
+172
| +0.8% | +$8.53K | 0.31% | 30 |
|
|
2025
Q3 | $1.03M | Hold |
21,844
| – | – | 0.3% | 32 |
|
|
2025
Q2 | $1.06M | Sell |
21,844
-948
| -4% | -$48.4K | 0.32% | 32 |
|
|
2025
Q1 | $1.26M | Hold |
22,792
| – | – | 0.38% | 33 |
|
|
2024
Q4 | $1.1M | Sell |
22,792
-172
| -0.7% | -$8.74K | 0.34% | 34 |
|
|
2024
Q3 | $1.32M | Hold |
22,964
| – | – | 0.4% | 32 |
|
|
2024
Q2 | $1.11M | Sell |
22,964
-192
| -0.8% | -$9.26K | 0.37% | 33 |
|
|
2024
Q1 | $1.13M | Hold |
23,156
| – | – | 0.37% | 35 |
|
|
2023
Q4 | $1.15M | Hold |
23,156
| – | – | 0.38% | 35 |
|
|
2023
Q3 | $1.24M | Hold |
23,156
| – | – | 0.43% | 35 |
|
|
2023
Q2 | $1.25M | Buy |
23,156
+388
| +2% | +$20.9K | 0.42% | 35 |
|
|
2023
Q1 | $1.24M | Sell |
22,768
-864
| -4% | -$42K | 0.42% | 34 |
|
|
2022
Q4 | $1.14M | Sell |
23,632
-140
| -0.6% | -$6.14K | 0.39% | 35 |
|
|
2022
Q3 | $904K | Buy |
23,772
+871
| +4% | +$38.8K | 0.35% | 36 |
|
|
2022
Q2 | $1.15M | Hold |
22,901
| – | – | 0.4% | 35 |
|
|
2022
Q1 | $1.18M | Sell |
22,901
-293
| -1% | -$15.1K | 0.39% | 36 |
|
|
2021
Q4 | $1.16M | Sell |
23,194
-871
| -4% | -$43.1K | 0.4% | 36 |
|
|
2021
Q3 | $1.16M | Hold |
24,065
| – | – | 0.42% | 31 |
|
|
2021
Q2 | $1.27M | Sell |
24,065
-777
| -3% | -$40.5K | 0.46% | 30 |
|
|
2021
Q1 | $1.23M | Hold |
24,842
| – | – | 0.46% | 30 |
|
|
2020
Q4 | $1.21M | Hold |
24,842
| – | – | 0.5% | 29 |
|
|
2020
Q3 | $1.25M | Hold |
24,842
| – | – | 0.6% | 29 |
|
|
2020
Q2 | $1.27M | Sell |
24,842
-22,300
| -47% | -$1.08M | 0.63% | 34 |
|
|
2020
Q1 | $2.06M | Hold |
47,142
| – | – | 1.18% | 29 |
|
|
2019
Q4 | $2.37M | Hold |
47,142
| – | – | 1.06% | 37 |
|
|
2019
Q3 | $2.18M | Buy |
47,142
+2,438
| +5% | +$105K | 1.04% | 36 |
|
|
2019
Q2 | $1.93M | Sell |
44,704
-266
| -0.6% | -$11.3K | 0.95% | 37 |
|
|
2019
Q1 | $1.99M | Sell |
44,970
-577
| -1% | -$24.7K | 0.98% | 36 |
|
|
2018
Q4 | $1.98M | Sell |
45,547
-122
| -0.3% | -$5.38K | 1.1% | 33 |
|
|
2018
Q3 | $2.04M | Sell |
45,669
-586
| -1% | -$25K | 1.04% | 33 |
|
|
2018
Q2 | $1.85M | Hold |
46,255
| – | – | 1.02% | 34 |
|
|
2018
Q1 | $1.85M | Buy |
46,255
+4,978
| +12% | +$207K | 1.03% | 35 |
|
|
2017
Q4 | $1.77M | Hold |
41,277
| – | – | 0.95% | 37 |
|
|
2017
Q3 | $2.06M | Hold |
41,277
| – | – | 1.17% | 31 |
|
|
2017
Q2 | $1.98M | Sell |
41,277
-610
| -1% | -$29.2K | 1.2% | 32 |
|
|
2017
Q1 | $1.9M | Sell |
41,887
-989
| -2% | -$42K | 1.18% | 31 |
|
|
2016
Q4 | $1.73M | Buy |
42,876
+959
| +2% | +$37.8K | 1.13% | 31 |
|
|
2016
Q3 | $1.6M | Buy |
41,917
+1,061
| +3% | +$42.6K | 1.05% | 31 |
|
|
2016
Q2 | $1.71M | Buy |
+40,856
| New | +$1.68M | 1.16% | 30 |
|
|
2014
Q3 | – | Sell |
-9,037
| Closed | -$480K | – | 49 |
|
|
2014
Q2 | $480K | Hold |
9,037
| – | – | 0.36% | 40 |
|
|
2014
Q1 | $472K | Hold |
9,037
| – | – | 0.37% | 45 |
|
|
2013
Q4 | $485K | Buy |
+9,037
| New | +$466K | 0.39% | 44 |
|
Other funds holding SNY
DC
QCM
MFG
FBT
FB
CAMG
PCM
AAM
BCM
Keystone Financial Planning's SNY Position: Q2 2026 in Review
Keystone Financial Planning reduced its Sanofi (SNY) stake by 0.65% in Q2 2026, selling an estimated $6.43K and leaving 21,872 shares worth $933K. The position accounts for 0.24% of the portfolio, ranked #29.
Keystone Financial Planning first reported a position in SNY in Q4 2013 and has held it in 44 quarters since. The position peaked at $2.37M in Q4 2019. 94 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- Keystone Financial Planning held 21,872 shares of Sanofi worth $933K as of Q2 2026.
- Keystone Financial Planning sold 144 Sanofi shares in Q2 2026, an estimated $6.43K.
- Sanofi made up 0.24% of Keystone Financial Planning's portfolio in Q2 2026, its #29 holding.
- Keystone Financial Planning first reported a position in Sanofi in Q4 2013 and has held it in 44 quarters since.
- Keystone Financial Planning's Sanofi position peaked at $2.37M in Q4 2019.
- 94 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on Keystone Financial Planning's 13F filing for Q2 2026, filed 15 Jul 2026.